search
Back to results

Shear-Wave Elastography in Intestinal Fibrosis Evaluation in Crohn's Disease (EL-CHIR)

Primary Purpose

Crohn Disease

Status
Recruiting
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
multimodal ultrasound
Sponsored by
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Crohn Disease

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: diagnosis of ileal or ileo-colonic Crohn's disease patients scheduled for elective intestinal resection for Crohn's disease within 30 days from enrollment affected intestinal segment detectable in B-mode ultrasound Exclusion Criteria: diagnosis of IBD other than Crohn's disease Crohn's disease without ileal involment lack of visualization of affected intestinal tract (eg. obesity) hearth failure known allergy to ultrasound contrast agents pregnancy lactation

Sites / Locations

  • Fondazione Policlinico Gemelli IRCCSRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Patients

Arm Description

Chron's disease patients scheduled for ileo-colonic resection

Outcomes

Primary Outcome Measures

liver stiffness values useful for assessing intestinal fibrosis and inflammation
to identify liver stiffness values (kPa) measured with shear-wave elastography that may predict the degree of bowel wall fibrosis or inflammation

Secondary Outcome Measures

Full Information

First Posted
March 16, 2023
Last Updated
September 25, 2023
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
search

1. Study Identification

Unique Protocol Identification Number
NCT06056986
Brief Title
Shear-Wave Elastography in Intestinal Fibrosis Evaluation in Crohn's Disease
Acronym
EL-CHIR
Official Title
Prospective Study to Evaluate the Role of Shear-Wave Elastography in Predicting the Degree of Intestinal Fibrosis in Patients With Crohn's Disease Who Are Candidates for Surgery - ElChir Study
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 18, 2020 (Actual)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The choice of the optimal timing for surgery in Crohn's disease is a challenging issue and diagnostic tools able to estimate the degree of fibrosis are of great interest in this context. Indeed, inflammatory intestinal loops are more likely to respond to medical therapies, wheareas fibrotic loops need to be treated surgically. Shear-wave elastography, which is a non-invasive and largely available technique for the study of tissue elasticity, is very promising and a recent meta-analysis has evaluated its diagnostic accuracy vs histologic examination in patients with stenosing Crohn's disease, showing encouraging results. Aim of this study is to evaluate the diagnostic agreement between elastographic parameters (mean, median, stability index) and the degree of intestinal fibrosis evaluated on the surgical specimen.
Detailed Description
Background: The choice of the optimal timing for surgery in Crohn's disease is a challenging issue and diagnostic tools able to estimate the degree of fibrosis are of great interest in this context. Indeed, inflammatory intestinal loops are more likely to respond to medical therapies, wheareas fibrotic loops need to be treated surgically. Shear-wave elastography, which is a non-invasive and largely available technique for the study of tissue elasticity, is very promising and a recent meta-analysis has evaluated its diagnostic accuracy vs histologic examination in patients with stenosing Crohn's disease, showing encouraging results. Primary aim: to evaluate the diagnostic agreement between elastographic parameters (mean, median, stability index) and the degree of intestinal fibrosis evaluated on the surgical specimen. Secondary aims: To evaluate the relationship between clinical disease activity assessed by the Harvey Bradshaw index and elastographic parameters. To evaluate the concordance between three different methods of shear wave elastography (point and 2D) and different machines. To identify elastographic cut-offs capable of predicting the presence and degree of fibrosis. To evaluate the agreement between elastography and magnetic resonance imaging (MRI) parameters of fibrosis in a subgroup of patients who underwent MRI preoperatively. Exploratory aims: To evaluate the relationship between elastographic parameters/fibrosis histological score and serum fibrosis biomarkers. To evaluate the relationship between elastographic parameters/fibrosis histological score and fecal microbiota. To evaluate the changes in serum biomarkers of fibrosis assayed pre- and post-operatively. To evaluate the changes in fecal microbiota analyzed pre-and post-operatively Study design: Prospective, interventional, single-center study Methods: Consecutive patients with ileal or ileo-colonic Crohn's disease needing to undergo ileo-cecal resection as per clinical practice with an affected intestinal segment detectable in B-mode ultrasound will be enrolled in the Unit of Internal Medicine and Gastroenterology of the Policlinico Gemelli. Exclusion criteria will be diagnosis of IBD other than Crohn's disease, Crohn's disease without ileal involment, lack of visualization of affected intestinal tract (eg. obesity), hearth failure, known allergy to ultrasound contrast agents, pregnancy and lactation. Considering that the primary objective is the evaluation of the agreement between the parameters obtained from three different elastography and the degree of intestinal fibrosis evaluated on the surgical specimen (histological) and assuming that the disagreement rate (for each single comparison) is 5%, with a confidence level of 0.05 and a power of 80%, a sample size of N=18 subjects is proposed. Upon informed consent, personal data and anamnesis will be collected within 30 days from the scheduled date for surgery (T0) and a venipuncture will be carried out as per normal clinical practice. Subsequently we will proceed with the ultrasound evaluation in B-mode for the identification of the target loop and the elastographic examination with two different ultrasounds (Esaote - MyLabTM9 and Aixplorer Mach 30® - SuperSonic Imagine) and three different technologies (point and 2D Esaote QElaxto ® and ShearWave™ Elastography-Supersonic Imagine). After surgical intervention, fibrosis scores will be calculated on the target loop by an expert Anatomo-Pathologist. Blood tests, ultrasound evaluations (B-mode ultrasound, elastography), surgery and histological examination of the intestinal specimen will be performed as per normal clinical practice. Data obtained from these procedures will be recorded and analyzed specifically for the study. The only study-specific procedures are the collection of fecal samples for microbiota evaluation, urine samples for metabolomics evaluation and an additional blood sample for evaluation of fibrosis biomarkers, all collected at T0 and 6-8 weeks after surgery (T1). The additional blood sample will be taken from the same peripheral venous access route used for blood sampling in normal clinical practice.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Crohn Disease

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
18 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Patients
Arm Type
Experimental
Arm Description
Chron's disease patients scheduled for ileo-colonic resection
Intervention Type
Diagnostic Test
Intervention Name(s)
multimodal ultrasound
Intervention Description
Dynamic contrast-enhanced ultrasound and shear wave elastography are perfomed on target intestinal loop
Primary Outcome Measure Information:
Title
liver stiffness values useful for assessing intestinal fibrosis and inflammation
Description
to identify liver stiffness values (kPa) measured with shear-wave elastography that may predict the degree of bowel wall fibrosis or inflammation
Time Frame
3 months after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: diagnosis of ileal or ileo-colonic Crohn's disease patients scheduled for elective intestinal resection for Crohn's disease within 30 days from enrollment affected intestinal segment detectable in B-mode ultrasound Exclusion Criteria: diagnosis of IBD other than Crohn's disease Crohn's disease without ileal involment lack of visualization of affected intestinal tract (eg. obesity) hearth failure known allergy to ultrasound contrast agents pregnancy lactation
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Maria Assunta Zocco
Phone
00393470597805
Email
mariaassunta.zocco@policlinicogemelli.it
Facility Information:
Facility Name
Fondazione Policlinico Gemelli IRCCS
City
Roma
ZIP/Postal Code
00168
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
MARIA ASSUNTA ZOCCO, PhD
Phone
00393470597805

12. IPD Sharing Statement

Learn more about this trial

Shear-Wave Elastography in Intestinal Fibrosis Evaluation in Crohn's Disease

We'll reach out to this number within 24 hrs